About ni2o
ni2o is a company based in Mclean (United States) founded in 2017. ni2o offers products and services including KIWI and ni2o RapidTest. ni2o operates in a competitive market with competitors including PhotoPharmics, Cala Health, Civitas Therapeutics, Sapiens Neuro and Kinetikos Health, among others.
- Headquarter Mclean, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$750 K (USD), Debt – Conventional
May 18, 2021
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ni2o
ni2o offers a comprehensive portfolio of products and services, including KIWI and ni2o RapidTest.
Minimally invasive implant for Parkinson's disease treatment
Rapid testing system for neurological conditions
People of ni2o
Unlock access to complete
Unlock access to complete
Funding Insights of ni2o
Investments & Acquisitions by ni2o
Investment portfolio details for ni2o
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ni2o
Detailed financials for ni2o
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ni2o Comparisons
Peer comparison for ni2o
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ni2o
ni2o operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PhotoPharmics, Cala Health, Civitas Therapeutics, Sapiens Neuro and Kinetikos Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive phototherapy for Parkinson's disease is developed.
|
|
| Locked | Locked | Locked |
Wearable neuromodulation devices for essential tremor relief are developed.
|
|
| Locked | Locked | Locked |
Inhaled pulmonary therapies for Parkinson's motor fluctuations are developed.
|
|
| Locked | Locked | Locked |
Developer of brain stimulation device to treat neurodegenerative disorders
|
|
| Locked | Locked | Locked |
Digital platform to assist healthcare providers and patients in the management of Parkinson’s disease
|
|
| Locked | Locked | Locked |
Non-invasive wearable devices for Parkinson's management are developed.
|
Detailed competitors of ni2o
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ni2o
Complete news archive for ni2o
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ni2o
ni2o was founded in 2017 and raised its 1st funding round 4 years after it was founded.
ni2o is headquartered in Mclean, United States. It is registered at Mclean, Virginia, United States.
Russ Hayward is the current CEO of ni2o.
NI2O is developing an AI-driven brain-computer interface. The company is developing Kiwi, a chip (size of rice grain) which can be implanted in the brain via the nasal cavity. The chip interacts with neurons using light and electrical impulses and will be used to treat neurological disorders, degenerative diseases, and cognitive enhancement. The company is in the stealth mode and looking for investors and partners as of June 2018.
ni2o's top competitors include PhotoPharmics, Cala Health and Aleva Neuro.
ni2o offers KIWI and ni2o RapidTest.